Taro Recalls Clotrimazole Cream Due to Unknown Impurity
Taro Pharmaceuticals is recalling Equate Athlete's Foot cream because an unknown impurity was detected above specification limits.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity where adverse health consequences are temporary or medically reversible, and no specific injuries or illnesses are reported in the source text.
Plain-English summary
Taro Pharmaceuticals U.S.A., Inc. is recalling 481,896 tubes of Equate Athlete's Foot, Clotrimazole USP 1%, Antifungal Cream. The product is available in 0.5 oz and 2 oz sizes and was distributed nationwide in the USA and Canada by Walmart Inc.
The recall was initiated because an unknown degradation impurity was detected slightly above the specification limit in the cream. This is a Class II recall, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers who have purchased this product should stop using it and return it to the place of purchase for a refund. Specific lot numbers and expiration dates are listed in the official recall notice.
The recalled product
- Product
- CLOTRIMAZOLE (CLOTRIMAZOLE)
- Brand
- CLOTRIMAZOLE
- Manufacturer
- Taro Pharmaceuticals U.S.A., Inc.
- Category
- Drug — Topical Antifungal
- Hazard
- Affected units
- 481,896
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lot#: a)A873430371
- Exp Dec-2020
- B870030918
- Exp Jan-2021
- C868330918
- Exp Feb-2021 b) A873430406
- A873530406
- A873630406
- B870030635
- B870130867
- C868330867
- Exp Feb-2021
UPCs (1)
- 0681131003797
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 10 recalled by Taro Pharmaceuticals U.S.A., Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same brand · CLOTRIMAZOLE
- ModerateClotrimazole cream, 1 ounce size, recalled over good manufacturing practice deviations
FDA (Drugs) · 2025-12-10
- ModerateClotrimazole cream, 5 ounce size, recalled over good manufacturing practice deviations
FDA (Drugs) · 2025-12-10
Same manufacturer · Taro Pharmaceuticals U.S.A., Inc.
See all →- ModerateHydrocortisone & Acetic Acid Otic Solution Recalled for Potency and Impurity Failures
FDA (Drugs) · 2024-08-21
- ModerateClotrimazole and Betamethasone Topical Cream Recalled for Failed Potency Specifications
FDA (Drugs) · 2022-04-06
- SevereClobetasol Propionate Ointment Recalled for Microbial Contamination
FDA (Drugs) · 2022-01-19
- HighTaro Recalls Nortriptyline Hydrochloride Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2021-02-10
- ModerateTaro Recalls Clotrimazole Cream Due to Unknown Degradation Impurity
FDA (Drugs) · 2020-12-23
Same hazard · impurity
See all →- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 30mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17